« Previous
Next »
American Heart Journal
Volume 152, Issue 4
, Pages 648-660
, October 2006
The impact of emergency department structure and care processes in delivering care for non–ST-segment elevation acute coronary syndromes
References
- Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. Circulation. 1998;98:1860–1868
- Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation. 2003;107:531–537
- The prognostic significance of serial myoglobin, troponin I, and creatine kinase–MB measurements in patients evaluated in the emergency department for acute coronary syndrome. Ann Emerg Med. 2003;42:343–350
- The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes. Ann Emerg Med. 2002;40:584–594
- . Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide. Rev Cardiovasc Med. 2003;4:S47–S55
- E. Braunwald, E.M. Antman, J.W. Beasley, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdf [Accessed on November 11, 2002]
- American Heart Association Get with the guidelines Available at: http://www.americanheart.org/presenter.jhtml/identifier=1165 [Accessed on December 24, 2002]
- Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001;87:819–822
- Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) initiative. JAMA. 2002;287:1269–1276
- National Registry of Myocardial Infarction. Available at: http://www.nrmi.org/index.html [Accessed on December 24, 2002].
- Improving the care of patients with non–ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med. 2002;9:1146–1155
- Millennium Pharmaceuticals, Inc CRUSADE index Available at: http://www.millennium.com/clinicians/cardiovascular/crusade/index.asp [Accessed on January 28, 2005]
- Early use of glycoprotein IIb/IIIa inhibitors in the ED treatment of non–ST-segment elevation acute coronary syndromes: a local quality improvement initiative. Am J Emerg Med. 2003;21:302–308
- . Utility of platelet ADP receptor antagonism in the emergency department: a review. J Emerg Med. 2003;24:45–54
- Acute coronary syndrome: pharmacotherapy. Prehosp Emerg Care. 2001;5:58–64
- Measuring and improving quality in emergency medicine. Acad Emerg Med. 2002;9:1091–1097
- The roles of senior management in quality improvement efforts: what are the key components?. J Healthc Manag. 2003;48:15–28
- . Health Forum LLC. Chicago: an affiliate of the American Hospital Association; 2004;
- . Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22
- Clinical inertia. Ann Intern Med. 2001;135:825–834
- Patient-reported frequency of taking aspirin in a population with coronary artery disease. Am J Cardiol. 2002;89:1042–1046
- Errors in a busy emergency department. Ann Emerg Med. 2003;42:324–333
- . “Crossing the quality chasm” in emergency medicine. Acad Emerg Med. 2002;9:1074–1077
- Regional variation in the treatment and outcomes of myocardial infarction: investigating New England's advantage. Am Heart J. 2003;146:242–249
- Geographic variation in the treatment of acute myocardial infarction: the cooperative cardiovascular project. JAMA. 1999;281:627–633
- Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI. JAMA. 2000;284:1256–1262
- Hospital-level performance improvement: beta-blocker use after acute myocardial infarction. Med Care. 2004;42:591–599
CRUSADE is funded by the Schering-Plough Corporation, Kenilworth, NJ. Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals Partnership, New York, NY and Paris, France, provides additional funding support. Millennium Pharmaceuticals, Inc, Cambridge, MA also provided funding for this work.
PII: S0002-8703(06)00344-9
doi: 10.1016/j.ahj.2006.04.015
© 2006 Mosby, Inc. All rights reserved.
« Previous
Next »
American Heart Journal
Volume 152, Issue 4
, Pages 648-660
, October 2006
